Bente L. Aalbers

Utrecht, UT 3584EA, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Functional, Cohort-Level Assessment of CFTR Modulator Responses Using Biobanked Nasal Epithelial Cells from Individuals with Cystic Fibrosis.

Functional, Cohort-Level Assessment of CFTR Modulator Responses Using Biobanked Nasal Epithelial Cells from Individuals with Cystic Fibrosis.

Journal: Journal of personalized medicine

Published: December 03, 2025

Centralized intestinal organoid generation is a feasible and safe approach for personalized medicine as demonstrated in the HIT-CF Europe Organoid Study.

Centralized intestinal organoid generation is a feasible and safe approach for personalized medicine as demonstrated in the HIT-CF Europe Organoid Study.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: January 12, 2024

Radiological and long-term clinical response to elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis with advanced lung disease.

Radiological and long-term clinical response to elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis with advanced lung disease.

Journal: Pediatric pulmonology

Published: August 17, 2022

Measuring cystic fibrosis drug responses in organoids derived from 2D differentiated nasal epithelia.

Measuring cystic fibrosis drug responses in organoids derived from 2D differentiated nasal epithelia.

Journal: Life science alliance

Published: November 26, 2021

Forskolin induced swelling (FIS) assay in intestinal organoids to guide eligibility for compassionate use treatment in a CF patient with a rare genotype.

Forskolin induced swelling (FIS) assay in intestinal organoids to guide eligibility for compassionate use treatment in a CF patient with a rare genotype.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: November 07, 2021

Management of Individual Patient Expectations When Starting with Highly Effective CFTR Modulators.

Management of Individual Patient Expectations When Starting with Highly Effective CFTR Modulators.

Journal: Journal of personalized medicine

Published: August 05, 2021

Females with cystic fibrosis have a larger decrease in sweat chloride in response to lumacaftor/ivacaftor compared to males.

Females with cystic fibrosis have a larger decrease in sweat chloride in response to lumacaftor/ivacaftor compared to males.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: March 02, 2020

Clinical effect of lumacaftor/ivacaftor in F508del homozygous CF patients with FEV1 ≥ 90% predicted at baseline.

Clinical effect of lumacaftor/ivacaftor in F508del homozygous CF patients with FEV1 ≥ 90% predicted at baseline.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: August 27, 2019

CRISPR-Based Adenine Editors Correct Nonsense Mutations in a Cystic Fibrosis Organoid Biobank.

CRISPR-Based Adenine Editors Correct Nonsense Mutations in a Cystic Fibrosis Organoid Biobank.

Journal: Cell stem cell

Published: July 02, 2019

Nasal potential difference in suspected cystic fibrosis patients with 5T polymorphism.

Nasal potential difference in suspected cystic fibrosis patients with 5T polymorphism.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: March 30, 2019

Showing 1-10 of 10

Last Updated: 09/26/2026